Fulltext

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Besse, B. ; Adjei, A. ; Baas, P. ; Meldgaard, P. ; Nicolson, M. ; Paz-Ares, L. ; Reck, M. ; Smit, E. F. ; Syrigos, K. ; Stahel, R. ; Felip, E. ; Peters, S. ; Stahel, Rolf ; Felip, Enriqueta ; Peters, Solange ; Kerr, Keith ; Besse, Benjamin ; Vansteenkiste, Johan ; Eberhardt, Wilfried ; Edelman, Martin ; Mok, Tony ; O'Byrne, Ken ; Novello, Silvia ; Bubendorf, Lukas ; Marchetti, Antonio ; Baas, Paul ; Reck, Martin ; Syrigos, Konstantinos ; Paz-Ares, Luis ; Smit, Egbert F. ; Meldgaard, Peter ; Adjei, Alex ; Nicolson, Marianne ; Crinò, Lucio ; Van Schil, Paul ; Senan, Suresh ; Faivre-Finn, Corinne ; Rocco, Gaetano ; Veronesi, Giulia ; Douillard, Jean-Yves ; Lim, Eric ; Dooms, Christophe ; Weder, Walter ; De Ruysscher, Dirk ; Le Pechoux, Cecile ; De Leyn, Paul ; Westeel, Virginie

In: Annals of Oncology, 2014, vol. 25, no. 8, p. 1475-1484

Aggiungi alla tua lista
    Titre
    • 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
    Auteur
    • Besse, B.. Thoracic Group, Department of Cancer Medicine, Gustave Roussy, Villejuif, France
    • Adjei, A.. Medicine Oncology, Roswell Park Cancer Institute, Buffalo, USA
    • Baas, P.. The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • Meldgaard, P.. Aarhus University Hospital, Aarhus, Denmark
    • Nicolson, M.. Aberdeen Royal Infirmary Anchor Unit, Aberdeen, UK
    • Paz-Ares, L.. Hospital Universitario Virgen del Rocio, Sevilla, Spain
    • Reck, M.. Department of Thoracic Oncology, Krankenhaus Grosshansdorf, Grosshansdorf, Germany
    • Smit, E. F.. Department of Pulmonary Diseases, Vrije University Medical Centre (VUMC), Amsterdam, The Netherlands
    • Syrigos, K.. Oncology Unit, Third Department of Medicine, Athens Chest Hospital Sotiria, Athens, Greece
    • Stahel, R.. Clinic of Oncology, University Hospital Zürich, Zürich, Switzerland
    • Felip, E.. Medical Oncology, Vall D'Hebron University Hospital, Barcelona, Spain
    • Peters, S.. Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
    • Stahel, Rolf. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Felip, Enriqueta. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Peters, Solange. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Kerr, Keith. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Besse, Benjamin. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Vansteenkiste, Johan. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Eberhardt, Wilfried. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Edelman, Martin. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Mok, Tony. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • O'Byrne, Ken. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Novello, Silvia. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Bubendorf, Lukas. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Marchetti, Antonio. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Baas, Paul. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Reck, Martin. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Syrigos, Konstantinos. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Paz-Ares, Luis. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Smit, Egbert F.. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Meldgaard, Peter. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Adjei, Alex. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Nicolson, Marianne. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Crinò, Lucio. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Van Schil, Paul. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Senan, Suresh. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Faivre-Finn, Corinne. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Rocco, Gaetano. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Veronesi, Giulia. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Douillard, Jean-Yves. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Lim, Eric. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Dooms, Christophe. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Weder, Walter. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • De Ruysscher, Dirk. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Le Pechoux, Cecile. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • De Leyn, Paul. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    • Westeel, Virginie. Gustave Roussy, Thoracic Group, Department of Cancer Medicine, Villejuif, Medicine Oncology, Buffalo, Amsterdam, Aarhus, Aberdeen, Sevilla, Department of Thoracic Oncology, Grosshansdorf, Department of Pulmonary Diseases, Amsterdam, Oncology Unit, Third Department of Medicine, Athens, Clinic of Oncology, Zürich, Medical Oncology, Barcelona, Oncology Department, Lausanne, France, USA, The Netherlands, Denmark, UK, Spain, Germany, The Netherlands, Greece, Switzerland, Spain, Switzerland
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • Annals of Oncology, 2014, vol. 25, no. 8, p. 1475-1484. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:293467
    Summary
    This manuscript provides recommendations for first-line / second and further lines of treatment in advanced disease in non-small cell lung cancer (NSCLC). These recommendations were developed during the 2nd ESMO Consensus Conference on Lung Cancer in May 2013